ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner.
Xu X, Chan AKN, Li M, Liu Q, Mattson N, Pangeni Pokharel S, Chang WH, Yuan YC, Wang J, Moore RE, Pirrotte P, Wu J, Su R, Müschen M, Rosen ST, Chen J, Yang L, Chen CW.
Xu X, et al. Among authors: yuan yc.
Sci Adv. 2022 Dec 23;8(51):eadc8911. doi: 10.1126/sciadv.adc8911. Epub 2022 Dec 23.
Sci Adv. 2022.
PMID: 36563143
Free PMC article.